SCHEMBL13147683

SCHEMBL13147683

Nc1cc(-c2ccc(-c3ccccc3)s2)nc(-c2nc(C(F)(F)F)cs2)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 1/20 0.41
C1S P09871 1/20 0.38
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B1 P14061 1/20 0.36
HSD17B2 P37059 1/20 0.36
ACHE P22303 1/20 0.36
IDH1 O75874 3/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
JAK2 O60674 1/20 0.35
ALPL P05186 2/20 0.34
ALPI P09923 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577156 0.88 HSD17B1 (0.42) KDM4EC1SMEN1ALDH1A1KMT2A
SCHEMBL13147660 0.86 IDH1 (0.39) ADORA2AADORA1KDM4EHSD17B10C1S
SCHEMBL13147664 0.84 ALDH1A1 (0.44) ADORA2AKDM4EHSD17B10C1SALDH1A1
SCHEMBL13147740 0.83 IDH1 (0.41) ADORA2AADORA1KDM4EHSD17B10ALDH1A1
SCHEMBL13147656 0.81 KDM4E (0.47) ADORA2AKDM4EHSD17B10MEN1ALDH1A1
SCHEMBL13147675 0.80 IDH1 (0.35) KDM4EHSD17B10MEN1ALDH1A1KMT2A
SCHEMBL577739 0.80 KDM4E (0.34) KDM4EHSD17B10C1SMEN1ALDH1A1
SCHEMBL13147684 0.79 RAB9A (0.41) ADORA2AADORA1KDM4EHSD17B10C1S
SCHEMBL13147661 0.78 IDH1 (0.37) KDM4EALDH1A1KMT2AIDH1
SCHEMBL13147742 0.78 IDH1 (0.37) ADORA2AADORA1KDM4EHSD17B10IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010118078-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2010-10-14 WO disclosed